01—Abstract
Summary
Summary of the 8-K filed January 29, 2025. Cited figures are marked; the original filing is the authoritative source.
Lam Research Corporation (LRCX) has entered into a Third Amended and Restated Credit Agreement, significantly enhancing its financial flexibility.
This agreement increases the company's revolving unsecured credit facility from $1.5 billion to $2.0 billiona, with an option to further expand it by an additional $750 million, potentially bringing the total commitment to $2.750 billion. The facility now matures on January 25, 2030, providing long-term access to capital for general corporate purposes. This updated credit facility reflects the company's strong financial standing and its proactive approach to managing its capital structure.
The terms include competitive interest rates based on the company's credit rating and a key financial covenant requiring a consolidated funded debt to adjusted EBITDA ratio of less than or equal to 3.50 to 1.00 (which can temporarily increase to 4.00 to 1.00 in connection with acquisitions). As of the filing date, no amounts were outstanding under the facility, indicating a strong liquidity position.
02—Key points
Key Highlights
- Increased revolving credit facility from $1.5 billion to $2.0 billion.
- Expansion option to increase facility by an additional $750 million, for a potential total of $2.750 billion.
- Maturity date extended to January 25, 2030, providing long-term funding.
- Proceeds from the facility are available for general corporate purposes.
- Interest rates are variable and based on the company's credit rating, offering cost efficiency.
- Key financial covenant limits consolidated funded debt to adjusted EBITDA to 3.50x (or 4.00x during acquisitions).
- No amounts were outstanding under the facility as of January 27, 2025, indicating strong current liquidity.
03—Questions
Frequently Asked Questions
What is the main purpose of this filing?
The main purpose of this filing is to announce Lam Research Corporation's entry into a Third Amended and Restated Credit Agreement, which significantly increases and modifies its revolving unsecured credit facility.
How does this new credit agreement benefit Lam Research?
The new agreement provides Lam Research with increased borrowing capacity ($2.0 billion, with potential for $2.75 billion), extended maturity (to 2030), and flexibility for general corporate purposes. This enhances the company's financial flexibility and access to capital.
What is the key financial metric Lam Research must maintain under this agreement?
Lam Research must maintain a consolidated funded debt to adjusted EBITDA ratio of less than or equal to 3.50 to 1.00. This ratio can temporarily be increased to 4.00 to 1.00 in connection with certain material acquisitions.
Is Lam Research currently using this credit facility?
No, as of January 27, 2025, no amount was outstanding under this facility, indicating that the company has sufficient liquidity without drawing on this credit line at this time.
04—Continue